Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Migraine (Adult) Clinical Trials

A listing of Migraine (Adult) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (44) clinical trials

A study of an investigational medicine in the treatment of Chronic Migraine. REF: x26-CLN  

Phase

BHV-3000 versus placebo in Acute Migraine. The study will recruit male and female patients 18 years of age and older with at least a one-year history of migraines (with or without aura), consistent with a diagnosis according to the International Classification of Headache Disorders, including an age of onset prior ...

Phase

People with Acute Migraines are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

This study will evaluate the safety and tolerability of the following doses of AGN-241689: 10 mg once daily (QD), 30 mg QD, 30 mg twice daily (BID), 60 mg QD, and 60 mg BID for the prevention of episodic migraine and will characterize the dose/response relationship.

Phase N/A

Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States

Phase

The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.

Phase N/A

A research study is evaluating an investigational medication for migraines.

Phase N/A

Don't wait, Participate! A clinical trial for migraines is now enrolling. Play an active role in your healthcare and contact us to see if you qualify to participate in this study.

Phase

Protocol #: 20150308 Migraine prevention in Subjects with Chronic Migraine (CM) or Episodic Migraine (EM) comparing the treatment medication AMG 301 to placebo.

Phase

This is a Prospective, Randomized, Vehicle‐controlled, Double‐blind, Multi-center, 3-arm study assessing the safety, tolerability, and efficacy of B244 delivered as an intranasal spray for preventive treatment in subjects with episodic migraine.

Phase